<narrative>Towards an equitable and sustainable response to HIV and tuberculosis in Bolivia, focusing on the well being of the key and vulnerable populations - Bolivia (Plurinational State) (01-Jan-2023-31-Dec-2025)</narrative>

47045-BOL-C-UNDP-1

The Global Fund to Fight AIDS, Tuberculosis and Malaria

<narrative>Towards an equitable and sustainable response to HIV and tuberculosis in Bolivia, focusing on the well being of the key and vulnerable populations - Bolivia (Plurinational State) (01-Jan-2023-31-Dec-2025)</narrative> Bolivia (Plurinational State), TB/HIV, United Nations Development Programme Goals: Contribuir con la reducción de nuevos casos de VIH/SIDA manteniendo la prevalencia por debajo de 0.30%, con enfoque en las poblaciones clave de mayor prevalencia en Bolivia; Reducir la incidencia de la tuberculosis en todas sus formas en 1,5% al 2025. Objectives: Mejorar el acceso de los gays, bisexuales y otros hombres que tienen sexo con hombres, mujeres trans y Trabajadoras sexuales a los servicios de prevención y diagnóstico del VIH; Fortalecer la vinculación, retención, acceso a tratamiento ARV y supresión de la carga viral de las personas viviendo con VIH; Ofertar servicios de atención, detección de casos, diagnóstico y tratamiento de la Tuberculosis, para reducir la carga de Tuberculosis en todas sus formas; Fortalecer la oferta de servicios de atención TB MDR, con el diagnóstico temprano, detección de casos, garantizando tratamiento y seguimiento; para reducir la carga de TB MDR.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

The Global Fund to Fight AIDS, Tuberculosis and Malaria

The Global Fund to Fight AIDS, Tuberculosis and Malaria Communications +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org

The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland

The Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Management Division

xxxx xxxx

Fund Portfolio Manager

+41 58 791 1700 xxxx https://www.theglobalfund.org

The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland

Bolivia (Plurinational State)

HIV Multicomponent, RSSH Tuberculosis Ensure healthy lives and promote well-being for all at all ages End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases Achieve universal health coverage

HIV -> Differentiated HIV Testing Services -> Community-based testing

HIV -> Differentiated HIV Testing Services -> Facility-based testing

HIV -> Prevention -> Behavior change interventions

HIV -> Prevention -> Condom and lubricant programming

HIV -> Prevention -> Needle and syringe programs

HIV -> Treatment, care and support -> Differentiated ART service delivery and HIV care

HIV -> Treatment, care and support -> Prevention and management of co-infections and co-morbidities (Treatment, care and support)

Multicomponent -> Program management -> Coordination and management of national disease control programs

Multicomponent -> Program management -> Grant management

RSSH -> RSSH: Health management information systems and M&E -> Routine reporting

RSSH -> RSSH: Health management information systems and M&E -> Surveys

Tuberculosis -> MDR-TB -> Case detection and diagnosis (MDR-TB)

Tuberculosis -> MDR-TB -> Prevention (MDR-TB)

Tuberculosis -> MDR-TB -> Treatment (MDR-TB)

Tuberculosis -> TB care and prevention -> Case detection and diagnosis (TB care and prevention)

Tuberculosis -> TB care and prevention -> Community TB care delivery

Tuberculosis -> TB care and prevention -> Engaging all care providers (TB care and prevention)

Tuberculosis -> TB care and prevention -> Key Populations (TB care and prevention) - Children

Tuberculosis -> TB care and prevention -> Key populations (TB care and prevention) - Prisoners

5218232.43

4323182.51

5270840.28

7444845.05 Global Fund commitment to BOL-C-UNDPP01.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

1875221.06 Global Fund disbursement to BOL-C-UNDPP01 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

199243.00 Global Fund disbursement to BOL-C-UNDPP01 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

1031564.78 Global Fund disbursement to BOL-C-UNDPP01 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

1056604.89 Global Fund disbursement to BOL-C-UNDPP01 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

25000.00 Global Fund commitment to BOL-C-UNDPP01.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

25000.00 Global Fund disbursement to BOL-C-UNDPP01 (Other 3rd Party).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

874770.06 Global Fund disbursement to BOL-C-UNDPP01 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

1543383.94 Global Fund disbursement to BOL-C-UNDPP01 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

-864057.32 Global Fund commitment to BOL-C-UNDPP01.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

4632322.12 Global Fund commitment to BOL-C-UNDPP01.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

1101542.12 Global Fund disbursement to BOL-C-UNDPP01 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

882924.00 Global Fund disbursement to BOL-C-UNDPP01 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

1783852.00 Global Fund disbursement to BOL-C-UNDPP01 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

2032547.15 Global Fund commitment to BOL-C-UNDPP01.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

-864004.00 Global Fund commitment to BOL-C-UNDPP01.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

1149759.15 Global Fund disbursement to BOL-C-UNDPP01 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

773952.00 Global Fund disbursement to BOL-C-UNDPP01 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

697574.50 Funds returned to the Global Fund from BOL-C-UNDPP01 (Other 3rd Party).

United Nations Development Programme

The Global Fund to Fight AIDS, Tuberculosis and Malaria

693127.50 Funds returned to the Global Fund from BOL-C-UNDPP01 (Other 3rd Party).

United Nations Development Programme

The Global Fund to Fight AIDS, Tuberculosis and Malaria

-693127.50 Global Fund commitment to BOL-C-UNDPP01.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

-697574.50 Global Fund commitment to BOL-C-UNDPP01.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

3397506.74 Expenditure reported by United Nations Development Programme for BOL-C-UNDPP01, Jan 2023 to Dec 2023.

United Nations Development Programme

4832828.47 Expenditure reported by United Nations Development Programme for BOL-C-UNDPP01, Jan 2024 to Dec 2024.

United Nations Development Programme

4463807.22 Expenditure reported by United Nations Development Programme for BOL-C-UNDPP01, Jan 2025 to Dec 2025.

United Nations Development Programme

<narrative>Grant page on the data explorer of the Global Fund.</narrative> An overview of a grant over its lifetime.

<narrative>Grant terms and conditions.</narrative> General terms and conditions which apply to Global Fund grants.

<narrative>2022 - Funding Request - Window 7 - TB/HIV - Bolivia (Plurinational State) - English</narrative> Funding Request of funding request FR1213-BOL-C.

<narrative>2022 - Funding Request - Window 7 - TB/HIV - Bolivia (Plurinational State) - Español</narrative> Funding Request of funding request FR1213-BOL-C.

<narrative>Percentage of men who have sex with men that have received an HIV test during the reporting period and know their results</narrative> Module: Differentiated HIV Testing Services. <narrative>Percentage of men who have sex with men that have received an HIV test during the reporting period and know their results</narrative> Geographic coverage: Subnational, 100% of national program target. Numerator: 12458; Denominator: 32407; Percentage: 38.44%. Numerator: 6270; Denominator: 23543; Percentage: 26.63%. Numerator: 6188; Denominator: 8864; Percentage: 69.81%. Numerator: 11532; Denominator: 12458; Percentage: 92.57%. Numerator: 926; Denominator: 12458; Percentage: 7.43%.

Numerator: 14799; Denominator: 33435; Percentage: 44.26%. Numerator: 11849; Denominator: 33435; Percentage: 35.4%.

Numerator: 15126; Denominator: 33952; Percentage: 44.55%. Numerator: 16699; Denominator: 33952; Percentage: 49.18%.

Numerator: 15444; Denominator: 34467; Percentage: 44.81%. Numerator: 18195; Denominator: 34467; Percentage: 52.79%. Numerator: 8919. Numerator: 9282. Numerator: 17114. Numerator: 1081.

<narrative>Percentage of sex workers that have received an HIV test during the reporting period and know their results</narrative> Module: Differentiated HIV Testing Services. <narrative>Percentage of sex workers that have received an HIV test during the reporting period and know their results</narrative> Geographic coverage: National, 100% of national program target. Numerator: 1771; Denominator: 20467; Percentage: 8.65%. Numerator: 1392. Numerator: 379. Numerator: 1771; Denominator: 20467; Percentage: 8.65%. Numerator: 1750; Denominator: 1771; Percentage: 98.81%. Numerator: 21; Denominator: 1771; Percentage: 1.19%.

Numerator: 2112; Denominator: 21116; Percentage: 10%. Numerator: 2197; Denominator: 21116; Percentage: 10.4%.

Numerator: 4505; Denominator: 21442; Percentage: 21.01%. Numerator: 6067; Denominator: 21442; Percentage: 28.29%.

Numerator: 6008; Denominator: 21768; Percentage: 27.6%. Numerator: 7436; Denominator: 21768; Percentage: 34.16%. Numerator: 5349. Numerator: 2117. Numerator: 7436. Numerator: 7381. Numerator: 55.

<narrative>Percentage of transgender people that have received an HIV test during the reporting period and know their results</narrative> Module: Differentiated HIV Testing Services. <narrative>Percentage of transgender people that have received an HIV test during the reporting period and know their results</narrative> Geographic coverage: Subnational, 100% of national program target. Numerator: 434; Denominator: 1705; Percentage: 25.45%. Numerator: 296; Denominator: 1239; Percentage: 23.89%. Numerator: 138; Denominator: 466; Percentage: 29.61%. Numerator: 381; Denominator: 434; Percentage: 87.79%. Numerator: 53; Denominator: 434; Percentage: 12.21%.

Numerator: 748; Denominator: 1759; Percentage: 42.52%. Numerator: 452; Denominator: 1759; Percentage: 25.7%.

Numerator: 772; Denominator: 1786; Percentage: 43.23%. Numerator: 708; Denominator: 1786; Percentage: 39.64%.

Numerator: 796; Denominator: 1814; Percentage: 43.88%. Numerator: 1243; Denominator: 1814; Percentage: 68.52%. Numerator: 865. Numerator: 381. Numerator: 1120. Numerator: 123.

<narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative> Module: MDR-TB. <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative> Geographic coverage: National, 100% of national program target.

<narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative> Module: MDR-TB. <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative> Geographic coverage: National, 100% of national program target.

<narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative> Module: Prevention. <narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative> Geographic coverage: Subnational, 100% of national program target. Numerator: 13177; Denominator: 32407; Percentage: 40.66%. Numerator: 6657; Denominator: 23543; Percentage: 28.28%. Numerator: 6520; Denominator: 8864; Percentage: 73.56%.

Numerator: 16000; Denominator: 33435; Percentage: 47.85%. Numerator: 13557; Denominator: 33435; Percentage: 40.5%.

Numerator: 16353; Denominator: 33952; Percentage: 48.17%. Numerator: 18970; Denominator: 33952; Percentage: 55.87%.

Numerator: 16697; Denominator: 34467; Percentage: 48.44%. Numerator: 21598; Denominator: 34467; Percentage: 62.66%. Numerator: 11027. Numerator: 10571.

<narrative>Percentage of sex workers reached with HIV prevention programs</narrative> Module: Prevention. <narrative>Percentage of sex workers reached with HIV prevention programs</narrative> Geographic coverage: National, 100% of national program target. Numerator: 2045; Denominator: 20467; Percentage: 9.99%. Numerator: 1599. Numerator: 446. Numerator: 2045; Denominator: 20467; Percentage: 9.99%.

Numerator: 2323; Denominator: 21116; Percentage: 11%. Numerator: 2368; Denominator: 21116; Percentage: 11.2%.

Numerator: 5170; Denominator: 21442; Percentage: 24.11%. Numerator: 6537; Denominator: 21442; Percentage: 30.49%.

Numerator: 6948; Denominator: 21768; Percentage: 31.92%. Numerator: 8131; Denominator: 21768; Percentage: 37.35%. Numerator: 5825. Numerator: 2306. Numerator: 8131.

<narrative>Percentage of transgender people reached with HIV prevention programs - defined package of services</narrative> Module: Prevention. <narrative>Percentage of transgender people reached with HIV prevention programs - defined package of services</narrative> Geographic coverage: Subnational, 100% of national program target. Numerator: 1314; Denominator: 1705; Percentage: 77.07%. Numerator: 895; Denominator: 1239; Percentage: 72.24%. Numerator: 419; Denominator: 466; Percentage: 89.91%.

Numerator: 1332; Denominator: 1759; Percentage: 75.72%. Numerator: 1728; Denominator: 1759; Percentage: 98.2%.

Numerator: 1390; Denominator: 1786; Percentage: 77.83%. Numerator: 2025; Denominator: 1786; Percentage: 113.38%.

Numerator: 1453; Denominator: 1814; Percentage: 80.1%. Numerator: 2599; Denominator: 1814; Percentage: 143.27%. Numerator: 1910. Numerator: 689.

<narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative> Module: TB care and prevention. <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative> Geographic coverage: National, 100% of national program target. Numerator: 5799; Denominator: 6016; Percentage: 96.39%. Numerator: 217; Denominator: 6016; Percentage: 3.61%. Numerator: 2218; Denominator: 6016; Percentage: 36.87%. Numerator: 3798; Denominator: 6016; Percentage: 63.13%. Numerator: 7140.

Numerator: 7800. Numerator: 9074.

Numerator: 8400. Numerator: 9644.

Numerator: 9000. Numerator: 10816. Numerator: 10462. Numerator: 354. Numerator: 3559. Numerator: 7257.

<narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid tests at the time of diagnosis</narrative> Module: TB care and prevention. <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid tests at the time of diagnosis</narrative> Geographic coverage: National, 100% of national program target. Numerator: 1245; Denominator: 6016.

Numerator: 3300; Denominator: 6600. Numerator: 7342; Denominator: 9074.

Numerator: 4680; Denominator: 7800. Numerator: 6328; Denominator: 9644.

Numerator: 6300; Denominator: 9000. Numerator: 9518; Denominator: 10816.

<narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative> Module: TB care and prevention. <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative> Geographic coverage: National, 100% of national program target. Numerator: 6228; Denominator: 7463.

Numerator: 7020; Denominator: 7800. Numerator: 6344; Denominator: 7998.

Numerator: 7560; Denominator: 8400. Numerator: 7291; Denominator: 9226.

Numerator: 8100; Denominator: 9000. Numerator: 7723; Denominator: 9603.

<narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative> Module: Treatment, care and support. <narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative> Geographic coverage: National, 100% of national program target. Numerator: 14113; Denominator: 26148. Numerator: 13820; Denominator: 25407. Numerator: 293; Denominator: 741. Numerator: 4128; Denominator: 9375. Numerator: 3988; Denominator: 9013. Numerator: 214; Denominator: 441. Numerator: 789; Denominator: 1792. Numerator: 575; Denominator: 1351. Numerator: 4429; Denominator: 8752. Numerator: 9985; Denominator: 16773. Numerator: 9832; Denominator: 16394. Numerator: 225; Denominator: 728. Numerator: 1534; Denominator: 2577. Numerator: 1309; Denominator: 1849. Numerator: 2211; Denominator: 14113. Numerator: 131; Denominator: 102.

Numerator: 16269; Denominator: 27659. Numerator: 16882; Denominator: 27659.

Numerator: 17354; Denominator: 28443. Numerator: 17898; Denominator: 28443.

Numerator: 18433; Denominator: 29227. Numerator: 19011; Denominator: 29227. Numerator: 18738; Denominator: 34824. Numerator: 273; Denominator: 783. Numerator: 5362; Denominator: 10529. Numerator: 5217; Denominator: 10134. Numerator: 199; Denominator: 340. Numerator: 765; Denominator: 1224. Numerator: 566; Denominator: 884. Numerator: 6374; Denominator: 11095. Numerator: 13529; Denominator: 24761. Numerator: 13521; Denominator: 24690. Numerator: 282; Denominator: 651. Numerator: 1696; Denominator: 2798. Numerator: 1414; Denominator: 2147. Numerator: 3005; Denominator: 19011. Numerator: 160; Denominator: 456.

47045-BOL-C-UNDP-2

The Global Fund to Fight AIDS, Tuberculosis and Malaria

<narrative>Advancing HIV and Tuberculosis Response in Bolivia and strengthening Community Systems to Ensure Sustainable Transition - Bolivia (Plurinational State) (01-Jan-2026-31-Dec-2027)</narrative> Bolivia (Plurinational State), TB/HIV, United Nations Development Programme Goals: Reducir la brecha de diagnostico de casos de Tuberculosis hasta el 10% al 2027 del numero de casos estimados por la OMS y aumentar la tasa de exito de tratamiento de la tuberculosis en todas sus formas, incluida la TB-DR. / Reduce the gap in TB diagnosis to 10% of the WHO-estimated number of cases by 2027 and increase the treatment success rate for all forms of TB, including DR-TB; Reducir la tasa de incidencia de VIH hasta 0,12 por mil habitantes para el año 2027. / Reduce the HIV incidence rate to 0.12 per thousand inhabitants by 2027. Objectives: Ofertar servicios de atención a la TB, tamizaje de TB presuntiva, detección de casos, diagnóstico y tratamiento de la Tuberculosis, para reducir la carga de Tuberculosis en todas sus formas. / Provide TB care services, presumptive TB screening, case detection, diagnosis, and treatment of tuberculosis to reduce the burden of tuberculosis in all its forms; Fortalecer la oferta de servicios de atención TB-DR, con el diagnóstico temprano, detección de casos, garantizando tratamiento y seguimiento para reducir la carga de TB-DR. / Strengthen the provision of DR-TB care services, with early diagnosis, case detection, and ensuring treatment and follow-up to reduce the burden of DR-TB; Mejorar el acceso de los hombres gays, bisexuales y otros hombres que tienen sexo con hombres, mujeres trans y trabajadoras sexuales a los servicios de prevención combinada y diagnóstico del VIH. / Improve access to combination HIV prevention and diagnostic services for gay, bisexual, and other men who have sex with men, transgender women, and sex workers; Fortalecer la vinculación, retención, acceso a tratamiento ARV y supresión de la carga viral de las personas viviendo con VIH. / Strengthen linkage, retention, access to ARV treatment, and viral load suppression among people living with HIV.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

The Global Fund to Fight AIDS, Tuberculosis and Malaria

The Global Fund to Fight AIDS, Tuberculosis and Malaria Communications +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org

The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland

The Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Management Division

xxxx xxxx

Fund Portfolio Manager

+41 58 791 1700 xxxx https://www.theglobalfund.org

The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland

Bolivia (Plurinational State)

HIV -> Differentiated HIV Testing Services -> Community-based testing for KP programs

HIV -> Differentiated HIV Testing Services -> Self-testing for KP programs

HIV -> Prevention package for men who have sex with men (MSM) and their sexual partners -> Condom and lubricant programming for MSM

HIV -> Prevention package for men who have sex with men (MSM) and their sexual partners -> HIV prevention communication, information and demand creation for MSM

HIV -> Prevention package for men who have sex with men (MSM) and their sexual partners -> Pre-exposure prophylaxis (PrEP) programming for MSM

HIV -> Prevention package for men who have sex with men (MSM) and their sexual partners -> Sexual and reproductive health services, including STIs, hepatitis, post-violence care for MSM

HIV -> Prevention package for sex workers, their clients and other sexual partners -> Condom and lubricant programming for sex workers

HIV -> Prevention package for sex workers, their clients and other sexual partners -> HIV prevention communication, information and demand creation for sex workers

HIV -> Prevention package for sex workers, their clients and other sexual partners -> Pre-exposure prophylaxis (PrEP) programming for sex workers

HIV -> Prevention package for sex workers, their clients and other sexual partners -> Sexual and reproductive health services, including STIs, hepatitis, post-violence care for sex workers

HIV -> Prevention package for transgender people and their sexual partners -> Condom and lubricant programming for transgender people

HIV -> Prevention package for transgender people and their sexual partners -> HIV prevention communication, information and demand creation for transgender people

HIV -> Prevention package for transgender people and their sexual partners -> Pre-exposure prophylaxis (PrEP) programming for transgender people

HIV -> Prevention package for transgender people and their sexual partners -> Sexual and reproductive health services, including STIs, hepatitis, post-violence care for transgender people

HIV -> Treatment, care and support -> Diagnosis and management of advanced HIV disease (adults and children)

HIV -> Treatment, care and support -> HIV treatment and differentiated service delivery - adults (15 and above)

HIV -> Treatment, care and support -> Treatment monitoring - Drug resistance

HIV -> Treatment, care and support -> Treatment monitoring - Viral load and antiretroviral (ARV) toxicity

Multicomponent -> Program management -> Grant management

RSSH -> RSSH: Community systems strengthening -> Capacity building and leadership development

RSSH -> RSSH: Community systems strengthening -> Community engagement, linkages and coordination

RSSH -> RSSH: Community systems strengthening -> Community-led research and advocacy

RSSH -> RSSH: Health financing systems -> Health financing data and analytics

RSSH -> RSSH: Health financing systems -> Health financing strategies and planning

RSSH -> RSSH: Monitoring and evaluation systems -> Routine reporting

RSSH -> RSSH: Monitoring and evaluation systems -> Surveillance for HIV, tuberculosis and malaria

Tuberculosis -> Drug-resistant (DR)-TB diagnosis, treatment and care -> DR-TB diagnosis/drug susceptibility testing (DST)

Tuberculosis -> Drug-resistant (DR)-TB diagnosis, treatment and care -> DR-TB treatment, care and support

Tuberculosis -> TB diagnosis, treatment and care -> TB screening and diagnosis

Tuberculosis -> TB/HIV -> TB/HIV - Collaborative interventions

Tuberculosis -> TB/HIV -> TB/HIV - Screening, testing and diagnosis

5749575.86

4440669.37

7969910.55 Global Fund commitment to BOL-C-UNDPP02.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

3449745.00 Global Fund disbursement to BOL-C-UNDPP02 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

1390702.00 Global Fund disbursement to BOL-C-UNDPP02 (Other 3rd Party).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

1390702.00 Global Fund commitment to BOL-C-UNDPP02.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

909129.00 Global Fund disbursement to BOL-C-UNDPP02 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

<narrative>Grant page on the data explorer of the Global Fund.</narrative> An overview of a grant over its lifetime.

<narrative>Grant terms and conditions.</narrative> General terms and conditions which apply to Global Fund grants.

<narrative>2025 - Funding Request - Window 7 - TB/HIV - Bolivia (Plurinational State) - English</narrative> Funding Request of funding request FR1679-BOL-C.

<narrative>2025 - Funding Request - Window 7 - TB/HIV - Bolivia (Plurinational State) - Español</narrative> Funding Request of funding request FR1679-BOL-C.

<narrative>Percentage of other vulnerable people that have received an HIV test during the reporting period and know their results</narrative> Module: Differentiated HIV Testing Services. <narrative>Percentage of other vulnerable people that have received an HIV test during the reporting period and know their results</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 15058; Denominator: 56310.

Numerator: 28906; Denominator: 59277.

Numerator: 31427; Denominator: 60319.

<narrative>Number of people with confirmed RR-TB and/or MDR-TB notified</narrative> Module: Drug-resistant (DR)-TB diagnosis, treatment and care. <narrative>Number of people with confirmed RR-TB and/or MDR-TB notified</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.

<narrative>Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment</narrative> Module: Drug-resistant (DR)-TB diagnosis, treatment and care. <narrative>Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 76; Denominator: 132.

Numerator: 155; Denominator: 182.

Numerator: 176; Denominator: 195.

<narrative>KP-6 Other1 Number of people who received any PrEP product at least once during the reporting period</narrative> Module: Prevention package for other vulnerable populations (OVP). <narrative>KP-6 Other1 Number of people who received any PrEP product at least once during the reporting period</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.

<narrative>Percentage of other vulnerable people reached with HIV prevention programs</narrative> Module: Prevention package for other vulnerable populations (OVP). <narrative>Percentage of other vulnerable people reached with HIV prevention programs</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 18213; Denominator: 56310.

Numerator: 31131; Denominator: 59277.

Numerator: 33765; Denominator: 60319.

<narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative> Module: TB diagnosis, treatment and care. <narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.

<narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative> Module: TB diagnosis, treatment and care. <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 6328; Denominator: 9644.

Numerator: 6760; Denominator: 10400.

Numerator: 7735; Denominator: 11050.

<narrative>Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB</narrative> Module: TB diagnosis, treatment and care. <narrative>Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 7291; Denominator: 9226.

Numerator: 8373; Denominator: 9850.

Numerator: 8944; Denominator: 10400.

<narrative>Percentage of people living with HIV and on ART with viral load test result</narrative> Module: Treatment, care and support. <narrative>Percentage of people living with HIV and on ART with viral load test result</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other. Numerator: 12285; Denominator: 16038.

Numerator: 18806; Denominator: 20895.

Numerator: 20773; Denominator: 22579.

Numerator: 24017; Denominator: 34906.

Numerator: 25953; Denominator: 36179.